The mobilization of cells from the bone marrow to the periphery has important implications in the treatment of blood cancers, as the mobilization of quiescent stem-like cells into the blood stream from their protective niches using CXCR4 antagonists should make them more susceptible to chemotherapy. The gene discussed is CXCR4; the disease is hematopoietic and lymphoid system neoplasm.